Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Huntleigh Technology's profits up 36% in first half of 1995:

This article was originally published in Clinica

Executive Summary

In the six months to June 30th, 1995, Huntleigh Technology (UK) reported pre-tax profits of £7.17 million ($11.5 million), up 36% on 1994's first half. Turnover rose 34% to £47.5 million. Chairman Rolf Schild expects "another record year" in 1995 and that new product launches will contribute to growth next year. The HNE Diagnostics division is in the process of launching new products, including Rheo Dopplex, a hand-held multifunctional device combining the Dopplex technology with digital photoplethysmography, for use in primary care and vascular assessment.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT093537

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel